Gloria Pharma Loses Out on Bid to Acquire Dilong Pharma

Harbin Gloria Pharma's impending deal to acquire Heilongjiang Dilong Pharma has fallen apart. Earlier this week, the two companies seemed ready to tie a knot, with only the price of the transaction remaining an issue. It didn’t help that a third company, as yet unnamed, joined the bidding process and apparently topped Gloria’s offer. Gloria was seeking to buy a 51% stake in Dilong. More details.... Stock Symbol: (SHE: 002437)     Share this with colleagues: